socalTECH

JANUARY 9, 2017

Thousand Oaks-based Amgen is the lead investor in a round for San Francisco- and Bozeman, Montana-based SiteOne Therapeutics , SiteOne said on Friday. SiteOne said it raised $15M in a Series B funding round, which was led b Amgen, and also included Next Frontier Capital and insiders.

Thousand Oaks 100

Thousand Oaks Invest Capital Funding 100

socalTECH

MARCH 8, 2016

Thousand Oaks-based Amgen has made another investment this morning in immunology startup Tizona Therapeutics , via its venture capital arm, Amgen Ventures. Series A investors--including Amgen Ventures--also participated, with investments from MPM Capital, Astellas Venture Management and InterWest Partners. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Funding Venture Capital Invest 100

socalTECH

DECEMBER 19, 2018

Thousand Oaks-based Amgen and Swiss biotech company Molecular Partners AG said Tuesday that the two are in a collaboration and licensing deal, for the commercialization of a molecule aimed at the immuno-oncology area. READ MORE>>.

Thousand Oaks 113

Thousand Oaks Design Activity Develop 113

socalTECH

DECEMBER 17, 2013

Thousand Oaks-based biopharmaceuticals startup Atara Biotherapeutics announced this morning that it has raised $38.5M in a Series B funding round, for its efforts to develop treatments for patients with end-stage renal disease. atara biotherapeutics venture capital renal disease lifescience amgen' READ MORE>>.

Thousand Oaks 180

Thousand Oaks Venture Capital Capital Funding 180

socalTECH

JANUARY 10, 2014

Thousand Oaks-based Atara Biotherapeutics announced this morning that it is in a second close of its Series B funding round, bringing its total raised in the funding to $52M. Atara is developing a number of biotherapeutics, including a treatment for protein energy wasting (PEW) and a treatment for ovarian cancer and other solid tumors.

Thousand Oaks 147

Thousand Oaks Capital Funding Invest 147

socalTECH

JULY 2, 2014

San Diego-based Ocean Aero , a developer of unmanned, autonomous marine vehicles, has scored funding from Thousand Oaks-based Teledyne , the companies said this morning. investment strategic capital venture marine ocean ship robot autonomous robotic oceanaero aero' Financial terms of the investment were not disclosed.

Thousand Oaks 147

Thousand Oaks Invest San Diego Design 147

socalTECH

OCTOBER 12, 2016

Thousand Oaks-based Akriveia Therapeutics , a biotechnology startup focused on immuno-oncology, announced this morning that it has raised $7.5M The investment came from F-Prime Capital Partners. in a Series A investment.

Thousand Oaks 100

Thousand Oaks Research Activity Invest 100

socalTECH

FEBRUARY 21, 2013

Xirrus , the wireless hardware provider based in Thousand Oaks, has just raised $10.1M Xirrus, which is backed by August Capital, Canaan Partners, InterWest Partners, QuestMark Partners, and US Venture Partners, last announced a funding round back in September. in a funding round, part of an ongoing $11.0M

Thousand Oaks 164

Thousand Oaks Conference Networking Capital 164

socalTECH

OCTOBER 9, 2015

Thousand Oaks-based Amgen has seen an exit out of its startup investment portfolio, and activities of its Amgen Ventures venture capital arm, at Berkeley-based Adheron Therapeutics this morning. Adheron said that it has been acquired by Roche , in a deal worth $105M upfront and up to $475M in additional milestone payments.

Thousand Oaks 100

Thousand Oaks Venture Capital Activity Capital 100

socalTECH

JANUARY 7, 2016

Thousand Oaks-based biotech giant Amgen is the a new investor in a round for Alector , a developer of immuno-modulatory therapies for Alzheimer's disease and other neurogenerative disorders, which announced a $29.5M funding today. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Google Research Funding 100

socalTECH

NOVEMBER 7, 2013

Thousand Oaks-based ImmunGene , a startup biotech company developing antibody-based, protein therapeutics for treating cancer, said today that it has raised $9M in a Series A funding, to advance its early stage development products. immungene venture capital biotech biotechnology cancer therapeutics' READ MORE>>.

Thousand Oaks 164

Thousand Oaks UCLA Venture Capital Equity 164

socalTECH

SEPTEMBER 8, 2011

Thousand Oaks-based biotech giant Amgen has backed a developer of therapeutic antibodies, via its venture capital arm, Amgen Ventures. Theraclone is developing therapeutic antibodies for treating infectious disease and cancer. READ MORE>>.

Thousand Oaks 150

Thousand Oaks Venture Capital Equity Capital 150

socalTECH

APRIL 10, 2012

Thousand Oaks-based biotech giant Amgen said this morning that it has agreed to buy KAI Pharmaceuticals , a developer of treatments for secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD) who are on dialysis, for $315M in cash. KAI Pharmaceuticals is based in South San Francisco. READ MORE>>.

Thousand Oaks 160

Thousand Oaks Capital Develop Development 160

socalTECH

APRIL 24, 2012

Amgen Ventures , the venture capital arm of Thousand Oaks-based Amgen , has re-upped on an investment in a biopharmaceuticals developing microRNA-based treatments for cardiovascular and muscle disease. and Broadview Ventures. miRagen is based in Boulder, Colorado.

Thousand Oaks 150

Thousand Oaks Venture Capital Invest Capital 150

socalTECH

SEPTEMBER 26, 2012

Thousand Oaks-based Xirrus , the developer of high speed, high performance wireless networking hardware, has raised another big chunk of financing, saying today that it has raised $23.5M in a Series E funding round. Xirrus said the funding will go towards sales growth and its product.

Networking 153

Networking Thousand Oaks Sales Capital 153

socalTECH

MAY 8, 2012

The venture capital arm of Thousand Oaks-based Amgen has placed more funding into one of its portfolio companies, Sutro Biopharma , which is working on developing a scalable biochemical protein synthesis platform aimed at cancer therapeutics. Sutro said it has raised $16.5M

Thousand Oaks 140

Thousand Oaks Invest Venture Capital Platform 140

socalTECH

APRIL 8, 2014

Thousand Oaks-based drug development company Atara Biotherapeutics announced this morning that it has added Matthew K. Fust as a board member, and hired Mitchall G. Clark as its Chief Regulatory and Quality Assurance Officer. READ MORE>>. atara biotherapeutics renal disease lifescience amgen executive board'

Thousand Oaks 138

Thousand Oaks Invest Capital Funding 138

socalTECH

JANUARY 24, 2011

Thousand Oaks-based biotech giant Amgen said Monday afternoon that it is acquiring Biovex , a Woburn, Massachusetts-based developer of treatments for melanoma and head and neck cancer. BioVex develops OncoVEX, a novel oncolytic vaccine in Phase 3 clinical development. READ MORE>>.

Thousand Oaks 167

Thousand Oaks Sales Invest Capital 167

socalTECH

AUGUST 31, 2011

Amgen Ventures , the venture capital arm of Thousand Oaks-based Amgen , has backed the developer of a biopharmaceutical aimed at treating irritable bowel syndrome, kidney disease, and diabetes.

Thousand Oaks 150

Thousand Oaks Venture Capital Capital Funding 150

socalTECH

JULY 6, 2015

Thousand Oaks-based Teledyne Technologies has increased its stake in San Diego-based Ocean Aero , a developer of unmanned, robotic underwater and surface vehicles used for the scientific, defense, and oil and gas market, the company said late Friday. Financial terms of the deal were not disclosed.

Thousand Oaks 100

Thousand Oaks San Diego Invest Marketing 100

socalTECH

FEBRUARY 28, 2012

Thousand Oaks-based Ceres , the developer of seed stock for energy crops, said today that it has closed its IPO, selling a total of 5,750,000 shares of its common stock at $13.00 Barclays Capital, Piper Jaffray, Raymond James, and Simmons & Company International. The firm is now trading around $15.08. READ MORE>>.

Thousand Oaks 140

Thousand Oaks Southern California Marketing Capital 140

socalTECH

FEBRUARY 22, 2012

Thousand Oaks-based Ceres , the developer of specialized seeds for the biofuels market, has priced its IPO, saying that it will offer up 5,000,000 shares of its common stock at $13.00 Barclays Capital, PIper Jaffray, Raymond James, and Simmons & Company International.

Pricing 150

Pricing Thousand Oaks Startup Design 150

socalTECH

JULY 2, 2010

Thousand Oaks-based Ceres , a developer of biofuel crop technology, has raised another $20M in funding, according to a regulatory filing from the firm Friday. Tags: warburg capital venture clean cleantech energy biofuel ceres. Source of the new funding was not disclosed. READ MORE>>.

Thousand Oaks 150

Thousand Oaks Equity Funding Capital 150

socalTECH

JANUARY 25, 2012

Thousand Oaks-based Ceres , the developer of seeds to supply the bioenergy and biofuels feedstock business, has set its initial pricing range for its IPO, according to a filing from the company this morning. Barclays Capital, Piper Jaffray, Raymond James, and Simmons & Company International. and $23.00

Pricing 145

Pricing Thousand Oaks Design Capital 145

socalTECH

MAY 23, 2011

Thousand Oaks-based Ceres , the developer of seeds aimed at producing renewable, biomass feedstocks for the biofuels industry, has filed for an IPO. and Barclays Capital. and Barclays Capital. The firm's IPO is being underwritten by Goldman, Sachs & co., The firm said it had a net loss of $22.5M READ MORE>>.

Thousand Oaks 140

Thousand Oaks .Net Capital Marketing 140

socalTECH

JANUARY 18, 2011

Thousand Oaks-based Xirrus , the venture backed developer of Wi-Fi equipment headed by Dirk Gates, said today that it has deployed its products at the Madison School District in Rexburg, Idaho. Xirrus is venture backed by August Capital, Canaan Partners, InterWest, QuestMark Partners, and US Venture Partners.

Thousand Oaks 140

Thousand Oaks Education Capital Product 140

socalTECH

APRIL 12, 2010

Thousand Oaks-based Nexsan , a developer of data storage systems, has delayed its IPO, according to its underwriter, Thomas Weisel Partners. The firm's IPO was being underwritten by Thomas Weisel Partners, Lazard Capital Markets, Needham & Company, and Morgan Keegan & Company.

Thousand Oaks 145

Thousand Oaks Marketing Capital Develop 145

socalTECH

JULY 8, 2010

Thousand Oaks-based Ceres , a developer of biofuels crop technology, said Thursday that it has completed a private offering of convertible preferred stock. Ceres is developing improved seed varieties--including. Tags: ceres venture capital biotech lifescience biofuel energy cleantech clean crop seed. READ MORE>>.

Thousand Oaks 140

Thousand Oaks Venture Capital Design Activity 140

socalTECH

NOVEMBER 25, 2009

Thousand Oaks-based Xirrus , a developer of Wi-Fi networking hardware, has raised another $20M in funding, according to a regulatory filing from the firm today. Xirrus has previously raised funding from US Venture Partners, August Capital, Canaan Partners, and QuestMark Partners. READ MORE>>.

Thousand Oaks 145

Thousand Oaks Funding Networking Platform 145

socalTECH

MAY 20, 2010

Thousand Oaks-based Ceres , a developer of biofuel crop technology, and Novozymes , a developer of enzymes, said today that the two have entered into a research collaboration around cellulosic biofuel production. Financial details of the partnership were not disclosed.

Thousand Oaks 145

Thousand Oaks Equity Research Product 145

socalTECH

DECEMBER 1, 2009

Thousand Oaks-based Xirrus confirmed Tuesday that it has raised an additional $20M in funding, bringing the firm's total raised to $80M. Xirrus is a developer of Wi-Fi networking hardware, which combines a number of Wi-Fi access points and switching in a single device. The round was led by InterWest Partners. READ MORE>>.

Thousand Oaks 140

Thousand Oaks Funding Venture Capital Networking 140

socalTECH

AUGUST 26, 2009

Thousand Oaks-based Xirrus , a developer of Wi-Fi networking hardware, has scored another education customer, the firm announced today. Xirrus develops Wi-Fi equipment which combines multiple wireless access points and switching, to provide better coverage and higher bandwidth to wireless deployments. READ MORE>>.

Education 133

Education Thousand Oaks Customer Custom 133

socalTECH

JUNE 29, 2010

Thousand Oaks-based Xirrus , which develops Wi-Fi networking devices, reported today that it has deployed its Wi-Fi arrays at the Corona-Norco Unified School District. The firm is backed by August Capital, Canaan Partners, Interwest, QuestMark, and U.S. Financial impact of the win was not disclosed. READ MORE>>.

Thousand Oaks 140

Thousand Oaks Education Networking Platform 140

socalTECH

OCTOBER 24, 2008

Thousand Oaks-based Xirrus has rolled out a new Wi-Fi array, the firm said earlier this week, the Xirrux XN8. Xirrus develops switched wireless Wi-Fi hardware which combines multiple Wi-Fi access points in a single piece of hardware. Pricing of the new hardware was not released. READ MORE>>

Thousand Oaks 124

Thousand Oaks Pricing Capital Product 124

socalTECH

FEBRUARY 2, 2009

Thousand Oaks-based wireless hardware provider Xirrus has scored a customer win in Australia, the firm disclosed this morning. Xirrus develops equipment which combines Wi-Fi access points with Ethernet switching, which enables better coverage, bandwidth, and performance for wireless connections. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Education Customer Custom 100

socalTECH

JANUARY 26, 2009

Thousand Oaks-based Xirrus, a developer of Wi-Fi network hardware, announced today that the firm's products have been deployed at a university in Russia. Xirrus is backed by August Capital, Canaan Partners, QuestMark Partners, and US Venture Partners, and is headed by Dirk Gates, former founder of Xircom. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Networking Customer Custom 100

socalTECH

MAY 18, 2009

Thousand Oaks-based Xirrus , a developer of Wi-Fi networking equipment, announced Monday that it has put together a portable, pre-packaged kit which is designed for deploying Wi-Fi into disaster response and temporary events. Venture Partners, August Capital, and QuestMark Partners. READ MORE>>.

Organization 100

Organization Thousand Oaks Conference Networking 100